We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $827M invested in Intra-Cellular Therapies Inc. in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
90% more call options, than puts
Call options by funds: $49.9M | Put options by funds: $26.3M
19% more capital invested
Capital invested by funds: $692M → $827M (+$135M)
0% more funds holding
Funds holding: 131 → 131 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
15% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 47
Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
40
Reduced
47
Closed
11
Calls
$49.9M
Puts
$26.3M
Net Calls
+$23.7M
Net Calls Change
+$8.87M
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$11.4M |
| 2 |
Millennium Management
New York
|
-$8.5M |
| 3 |
PC
PointState Capital
New York
|
-$8.39M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.36M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.31M |
